Legend Biotech Corp

Research Legend Biotech Corp (LEGN) on Bullrun: market cap USD 5.46B. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerLEGN
• ExchangeNASDAQ
• CountryUnited States
• SectorHealthcare
• IndustryBiotechnology
• CurrencyUSD
• Market capUSD 5.46B
• Financial periodQ1 2026
• RevenueUSD 305.10M
• Net income-USD 54.30M
• Free cash flow-USD 115.80M
• Gross margin205.3%

Valuation Snapshot

latest market cap is USD 5.46B.

About Legend Biotech Corp

Legend Biotech Corporation, through its subsidiaries, operates as a biopharmaceutical company that discovers, develops, manufactures, and commercializes novel cell therapies for oncology and other indications in the United States, China, and Europe. Its lead product candidate is ciltacabtagene autoleucel, or cilta-cel, which is a chimeric antigen receptor (CAR-T) therapy for the treatment of multiple myeloma (MM).

Frequently asked questions

What is Legend Biotech Corp's market cap?

Legend Biotech Corp's market capitalization is USD 5.46B.

What does Legend Biotech Corp do?

Legend Biotech Corporation, through its subsidiaries, operates as a biopharmaceutical company that discovers, develops, manufactures, and commercializes novel cell therapies for oncology and other indications in the United States, China, and Europe.